CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 15 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18 | -30.8% | 24 | 0.0% | 0.00% | – |
| Q2 2023 | $26 | -60.6% | 24 | -63.6% | 0.00% | – |
| Q1 2023 | $66 | -8.3% | 66 | -20.5% | 0.00% | – |
| Q4 2022 | $72 | – | 83 | -4.6% | 0.00% | – |
| Q3 2022 | $0 | – | 87 | -52.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 184 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $6,894,000 | -60.8% | 2,283,269 | -33.2% | 0.00% | 0.0% |
| Q4 2021 | $17,601,000 | -84.7% | 3,417,564 | -29.1% | 0.00% | -88.9% |
| Q3 2021 | $115,154,000 | +50.2% | 4,818,189 | +22.7% | 0.01% | +50.0% |
| Q2 2021 | $76,672,000 | +30.1% | 3,925,836 | +23.3% | 0.01% | +20.0% |
| Q1 2021 | $58,922,000 | – | 3,184,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,991,003 | $6,990,304 | 0.16% |
| Kynam Capital Management, LP | 739,649 | $739,575 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $219,479 | 0.05% |
| UBS OCONNOR LLC | 574,148 | $574,148 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,027,519 | $1,027,416 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $26,864 | 0.00% |
| JPMORGAN CHASE & CO | 78,547 | $79,000 | 0.00% |
| Renaissance Technologies | 89,100 | $89 | 0.00% |
| ROYAL BANK OF CANADA | 41 | $0 | 0.00% |
| UBS Group AG | 9,336 | $9,336 | 0.00% |